{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:13:30Z","timestamp":1774361610747,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.amjsurg.2003.07.019","type":"journal-article","created":{"date-parts":[[2003,11,2]],"date-time":"2003-11-02T06:09:25Z","timestamp":1067753365000},"page":"460-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion"],"prefix":"10.1016","volume":"186","author":[{"given":"Tsung-Yen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Abdul-Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Yun","family":"Leu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Fang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Petros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Aloia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Fedrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Pruitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2003.07.019_BIB1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9610(85)90006-6","article-title":"Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity","volume":"15","author":"Storm","year":"1985","journal-title":"Am J Surg"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB2","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/1097-0142(19890615)63:12<2551::AID-CNCR2820631233>3.0.CO;2-7","article-title":"Prognostic variables in recurrent limb melanoma treated with hyperthermic aniblastic perfusion","volume":"63","author":"Di Filippo","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bjs.1800770716","article-title":"Hyperthermic isolated limb perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb","volume":"77","author":"Skene","year":"1990","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB4","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E","article-title":"A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma","volume":"55","author":"Minor","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB5","first-page":"39","article-title":"Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan","volume":"115","author":"Klaase","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB6","first-page":"441","article-title":"Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs","volume":"7","author":"Kroon","year":"1987","journal-title":"Anticancer Res"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB7","series-title":"Cutaneous melanoma","first-page":"281","article-title":"Hyperthermic regional perfusion for melanoma of the limbs","author":"Fraker","year":"1998"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB8","unstructured":"Aloia T, Grubbs E, Onaitis M, et al. The ability to achieve a complete response post hyperthermic isolated limb perfusion is the strongest predictor of survival. Proc Soc Surg Oncol 2001"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB9","first-page":"351","article-title":"A phase I study of melphalan in 40 C isolated limb perfusion using packed red blood cells and lactated ringers perfusate","volume":"11","author":"Boddie","year":"1992","journal-title":"Proc ASCO"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00000658-199410000-00010","article-title":"Regional chemotherapy for melanoma","volume":"220","author":"Krementz","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0378-4347(00)85172-5","article-title":"Modified extraction and chromatography for the measurment of plasma melphalan by ion-pair high-performance liquid chromatography","volume":"336","author":"Adair","year":"1984","journal-title":"J Chromatogr"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB13","first-page":"1885","article-title":"Pharmacokinetics of melphalan in clinical isolation perfusion of the extremities","volume":"45","author":"Briele","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB14","first-page":"83","article-title":"Clinical pharmacokinetics of melphalan in isolated limb perfusion","volume":"8","author":"Thompson","year":"1995","journal-title":"Reg Cancer Treat"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB15","first-page":"157","article-title":"Pharmacokinetics of alkylating agent","volume":"17","author":"Lind","year":"1993"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)25058-3","article-title":"Pharmacokientics of melphalan in isolated perfusion of the limbs","volume":"237","author":"Benckhuijsen","year":"1985","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB17","series-title":"Principle of clinical pharmacology","author":"Atkinson","year":"2001"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB18","series-title":"Pharmacokinetics of drugs","first-page":"507","article-title":"Consideration on data analysis using computer methods and currently available software for personal computers","author":"Gex-Fabry","year":"1994"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB19","unstructured":"User's guide: WinNonlin version 2.1. Scientific Consulting, Inc"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF01059788","article-title":"The importance of tissue distribution in pharmacokinetics","volume":"1","author":"Gillette","year":"1973","journal-title":"J Pharmacokinetics Biopharm"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01062109","article-title":"Statistical moments in pharmacokinetics","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J Pharmacokin Biopharm"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1072-7515(99)00018-6","article-title":"Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma","volume":"188","author":"Vrouenraets","year":"1999","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archsurg.1995.01430010045009","article-title":"Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions","volume":"130","author":"Vrouenraets","year":"1995","journal-title":"Arch Surg"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9610(94)90111-2","article-title":"Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities","volume":"167","author":"Klaase","year":"1994","journal-title":"Am J Surg"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00008390-199606000-00010","article-title":"Determinants of acute regional toxicity following isolated limb perfusion for melanoma","volume":"6","author":"Thompson","year":"1996","journal-title":"Melanoma Res"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<224::AID-SSU6>3.0.CO;2-A","article-title":"Toxicity and morbidity of isolated limb perfusion","volume":"14","author":"Vrouenraets","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00008390-200112000-00007","article-title":"Saturable dose-response relationships for melphalan in melanoma treatment by isolated limb infusion in the nude rat","volume":"11","author":"Roberts","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00273524","article-title":"High-dose melphalan dosage adjustment","volume":"23","author":"Tranchand","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/0959-8049(92)90506-W","article-title":"Pharmacokinetically guided dosing for intravenous melphalan","volume":"28A","author":"Ploin","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/bjc.1994.266","article-title":"Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb","volume":"70","author":"Klaase","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.amjsurg.2003.07.019_BIB31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmacokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin Pharmacokinet"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296100300343X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296100300343X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:33:59Z","timestamp":1757698439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296100300343X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S000296100300343X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2003.07.019","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2003.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}